Filed: 8/14/2026ACC: 0001193125-26-352338
📋 What this filing means
ALLY BRIDGE GROUP (NY) LLC filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $113.07M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$113.07M
Total AUM (reported)
11.78M
Total Shares
Allocation by class
COM$39.40M34.8%
COM SHS$26.98M23.9%
SPONSORED ADS$19.43M17.2%
COM NEW$19.14M16.9%
ORD SHS$5.72M5.1%
ADS$2.40M2.1%
Portfolio Concentration
Top 3$47.55M42.1%
4–10$32.15M28.4%
11–25$33.37M29.5%
Top 3 weight
42.1%
Top 10 weight
70.5%
Voting Authority Distribution
Total shares with voting rights: 11.26M
Sole
Full voting authority
11.26M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
DEFINIUM THERAPEUTICS INC
SOLEShares400K
TypeSH
Market value$18.82M
16.64%
Sole
0.00
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares125K
TypeSH
Market value$16.66M
14.73%
Sole
0.00
Shared
0.00
None
0.00
MINERVA NEUROSCIENCES INC
SOLEShares2.18M
TypeSH
Market value$12.08M
10.68%
Sole
2.18M
Shared
0.00
None
0.00
PROMIS NEUROSCIENCES INC
SOLEShares620.32K
TypeSH
Market value$8.16M
7.22%
Sole
620.32K
Shared
0.00
None
0.00
FIRST TRACKS BIOTHERAPEUTICS
SOLEShares284.29K
TypeSH
Market value$5.72M
5.06%
Sole
284.29K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares16.49K
TypeSH
Market value$4.04M
3.57%
Sole
16.49K
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares140K
TypeSH
Market value$3.85M
3.40%
Sole
140K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares817.94K
TypeSH
Market value$3.75M
3.31%
Sole
817.94K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares83.30K
TypeSH
Market value$3.38M
2.99%
Sole
83.30K
Shared
0.00
None
0.00
CLIMB BIO INC
SOLEShares249.17K
TypeSH
Market value$3.25M
2.87%
Sole
249.17K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares290K
TypeSH
Market value$3.18M
2.81%
Sole
290K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC.
SOLEShares775K
TypeSH
Market value$2.91M
2.57%
Sole
775K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares150K
TypeSH
Market value$2.77M
2.45%
Sole
150K
Shared
0.00
None
0.00
PALISADE BIO INC
SOLEShares1.23M
TypeSH
Market value$2.57M
2.27%
Sole
1.23M
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares255.96K
TypeSH
Market value$2.56M
2.26%
Sole
255.96K
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares526.32K
TypeSH
Market value$2.55M
2.25%
Sole
526.32K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares69.18K
TypeSH
Market value$2.55M
2.25%
Sole
69.18K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares743.96K
TypeSH
Market value$2.54M
2.24%
Sole
743.96K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares67.50K
TypeSH
Market value$2.52M
2.22%
Sole
67.50K
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares634.80K
TypeSH
Market value$2.40M
2.12%
Sole
634.80K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares76.46K
TypeSH
Market value$2.15M
1.90%
Sole
76.46K
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares624.56K
TypeSH
Market value$1.68M
1.49%
Sole
624.56K
Shared
0.00
None
0.00
EUPRAXIA PHARMACEUTICALS INC
SOLEShares252.18K
TypeSH
Market value$1.67M
1.47%
Sole
252.18K
Shared
0.00
None
0.00
IBIO INC
SOLEShares390.15K
TypeSH
Market value$682.8K
0.60%
Sole
390.15K
Shared
0.00
None
0.00
TRAWS PHARMA INC
SOLEShares786.24K
TypeSH
Market value$663.0K
0.59%
Sole
786.24K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 400K | SH | $18.82M 16.64% | 0.00 | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 125K | SH | $16.66M 14.73% | 0.00 | 0.00 | 0.00 |
MINERVA NEUROSCIENCES INCSOLE | COM NEW | 2.18M | SH | $12.08M 10.68% | 2.18M | 0.00 | 0.00 |
PROMIS NEUROSCIENCES INCSOLE | COM SHS | 620.32K | SH | $8.16M 7.22% | 620.32K | 0.00 | 0.00 |
FIRST TRACKS BIOTHERAPEUTICSSOLE | ORD SHS | 284.29K | SH | $5.72M 5.06% | 284.29K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 16.49K | SH | $4.04M 3.57% | 16.49K | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 140K | SH | $3.85M 3.40% | 140K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 817.94K | SH | $3.75M 3.31% | 817.94K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 83.30K | SH | $3.38M 2.99% | 83.30K | 0.00 | 0.00 |
CLIMB BIO INCSOLE | COM | 249.17K | SH | $3.25M 2.87% | 249.17K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 290K | SH | $3.18M 2.81% | 290K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INC.SOLE | COM | 775K | SH | $2.91M 2.57% | 775K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | SPONSORED ADS | 150K | SH | $2.77M 2.45% | 150K | 0.00 | 0.00 |
PALISADE BIO INCSOLE | COM | 1.23M | SH | $2.57M 2.27% | 1.23M | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM | 255.96K | SH | $2.56M 2.26% | 255.96K | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 526.32K | SH | $2.55M 2.25% | 526.32K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 69.18K | SH | $2.55M 2.25% | 69.18K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 743.96K | SH | $2.54M 2.24% | 743.96K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 67.50K | SH | $2.52M 2.22% | 67.50K | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 634.80K | SH | $2.40M 2.12% | 634.80K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 76.46K | SH | $2.15M 1.90% | 76.46K | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 624.56K | SH | $1.68M 1.49% | 624.56K | 0.00 | 0.00 |
EUPRAXIA PHARMACEUTICALS INCSOLE | COM | 252.18K | SH | $1.67M 1.47% | 252.18K | 0.00 | 0.00 |
IBIO INCSOLE | COM NEW | 390.15K | SH | $682.8K 0.60% | 390.15K | 0.00 | 0.00 |
TRAWS PHARMA INCSOLE | COM | 786.24K | SH | $663.0K 0.59% | 786.24K | 0.00 | 0.00 |